Oncomine Precision Assay

Oncomine Precision Assay receives breakthrough device designation by the U.S FDA

Oncomine Precision Assay receives breakthrough device designation by the U.S FDA. Next-generation sequencing solutions of  ThermoFisher Scientific helps to identify IDH1 and IDH2 mutations in low-grade glioma patients. Mumbai :

Read More